Clin2
NCT06747390Likely a fitRecruiting

Lidocaine injection before throat cancer surgery

Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma VirusSquamous Cell Carcinoma

Treatments studied

Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.

This early-phase trial tests whether injecting lidocaine (a numbing medicine) into the tumor before surgery can help with pain or other outcomes in people with oropharyngeal cancer. It's for patients who are already scheduled for a scope procedure and surgery at the University of Pennsylvania.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with squamous cell carcinoma of the oropharynx (back of the throat) or neck.
  • Your tumor is at a stage T1, T2, T3, or T4 (any stage of local spread).
  • You are planning to have a direct laryngoscopy (scope to look at the throat) with or without biopsy at the University of Pennsylvania.
  • You have not had radiation therapy to the head or neck before.
  • You are not allergic to lidocaine or similar numbing medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07392580Recruiting· Phase 2
Chemo injection before surgery for recurrent throat cancer

This trial tests injecting a chemotherapy drug (cisplatin with epinephrine) directly into throat tumors, given once a week for 3 weeks before planned surgery. It is for people whose throat cancer has come back after radiation and who need surgery to remove it.

Miami, Florida
NCT05098119Recruiting· Phase 2
Study drugs before surgery for mouth or throat cancer

This Phase 2 trial tests giving the immunotherapy drug sintilimab before surgery, along with fewer chemotherapy cycles. The goal is to shrink or control oral or throat squamous cell cancers while keeping side effects lower, before the tumor is removed.

Guangzhou, Guangdong
NCT07347977Not yet recruiting
Lidocaine after lung cancer surgery to reduce risk of recurrence

This trial tests whether giving lidocaine during and after lung cancer surgery can reduce the chance of the cancer coming back or spreading. If you are having minimally invasive surgery for lung cancer, this study may help improve your long-term outcome.

Ningbo, Zhejiang
NCT06702033Recruiting· Phase 2
Surgery for HPV-related oropharyngeal cancer

This trial is testing a surgical approach for people with HPV-related oropharyngeal cancer that is stage I or II (but not the very smallest). The goal is to see if removing the tumor through the mouth and taking out neck lymph nodes is effective and safe. It may be an option if you are healthy enough for surgery.

St Louis, Missouri
NCT07110857Not yet recruiting
Numbing neck nerves for throat cancer surgery

This study tests whether numbing the nerves in the neck before throat or neck cancer surgery can reduce pain and improve recovery. It compares the standard anesthesia with an additional nerve block to see if it helps patients feel better after surgery.

Lille
NCT06894459Not yet recruiting· Phase 2
Immunotherapy and chemotherapy before surgery for advanced throat cancer

This trial tests whether giving a combination of an immunotherapy drug (PD-1 inhibitor) and chemotherapy before surgery can help treat advanced throat cancer. The goal is to see if this approach shrinks tumors and improves outcomes.

Hear when a new Oropharyngeal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.